PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 18, 2026JNCI Journal of the National Cancer Institute2 citations

Menopausal hormone therapy and risk of esophageal and gastric cancer in a multi-national study

View Full Paper
VWVictoria WocalewskiGSGiola B. SantoniHBHelgi Birgisson

Key Points

  • To assess the association between menopausal hormone therapy and the risk of esophago-gastric cancer.
  • Conducted a multi-national analysis
  • Tracked cancer incidence among hormone therapy users and non-users
  • MHT-users display significantly lower odds of esophago-gastric cancer development
  • Findings suggest a protective effect of menopausal hormone therapy against these cancers

Abstract

MHT-users seem to have lower odds of developing esophago-gastric cancer.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wocalewski et al. (2026) studied this question.

synapsesocial.com/papers/69ba43d84e9516ffd37a5713https://doi.org/10.1093/jnci/djag072
Ask AI
Helpful
Bookmark
Share
View Full Paper